Aigen Investment Management LP Takes $2.46 Million Position in Cardinal Health, Inc. $CAH

Aigen Investment Management LP purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 11,954 shares of the company’s stock, valued at approximately $2,457,000.

Other institutional investors have also recently bought and sold shares of the company. Atlas Capital Advisors Inc. acquired a new position in Cardinal Health during the 4th quarter worth approximately $1,854,000. Aptus Capital Advisors LLC boosted its position in Cardinal Health by 31.3% during the 4th quarter. Aptus Capital Advisors LLC now owns 3,370 shares of the company’s stock worth $693,000 after acquiring an additional 803 shares during the last quarter. CreativeOne Wealth LLC boosted its position in Cardinal Health by 15.7% during the 4th quarter. CreativeOne Wealth LLC now owns 9,577 shares of the company’s stock worth $1,968,000 after acquiring an additional 1,300 shares during the last quarter. Kestra Advisory Services LLC boosted its position in Cardinal Health by 13.8% during the 4th quarter. Kestra Advisory Services LLC now owns 20,241 shares of the company’s stock worth $4,159,000 after acquiring an additional 2,458 shares during the last quarter. Finally, Transamerica Financial Advisors LLC boosted its position in Cardinal Health by 90.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 1,837 shares of the company’s stock worth $377,000 after acquiring an additional 873 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 1.2%

CAH opened at $223.76 on Friday. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The stock’s fifty day simple moving average is $203.21 and its 200 day simple moving average is $208.85. The stock has a market cap of $52.41 billion, a PE ratio of 34.21, a price-to-earnings-growth ratio of 1.22 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the prior year, the business earned $2.35 EPS. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CAH. William Blair began coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Wells Fargo & Company reduced their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Citigroup reduced their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Robert W. Baird set a $248.00 price objective on Cardinal Health in a research note on Friday, May 1st. Finally, Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 7th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.